Total Synthesis of Anticancer Natural Products Using Oxidative Dearomatization
Total Synthesis of Anticancer Natural Products Using Oxidative Dearomatization
批准号:
9171740
负责人:
Yu Yuan
金额:
$43.62万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-15 至 2020-12-31
关键词:
Academic Research Enhancement AwardsAlkaloidsAllyAntineoplastic AgentsBasic ScienceBiologicalBiologyCancer PatientCarbonCause of DeathCellsCephalotaxusCessation of lifeChemicalsComplexDataDevelopmentDoseDrug IndustryEconomic BurdenElectron TransportElectronsElementsExhibitsFamilyInterceptInvestigationLaboratoriesLongevityLymphomaMalignant NeoplasmsMedicalMethodologyMethodsMusNatural ProductsNavelbine ditartrateNerve Growth FactorsNorditerpenoidsOctanesOrganic SynthesisOutcomeOxidantsPaclitaxelPatientsPhenolsPositioning AttributeProtocols documentationRadiation therapyReactionReagentRegimenReportingResearchScienceScientistSkeletonSocietiesSolid NeoplasmStructureStructure-Activity RelationshipSystemTestingTherapeutic AgentsUnited StatesUnited States Food and Drug AdministrationUp-RegulationVasodilationalkaloid skeletonanaloganticancer activitybasechemotherapycycloadditioncytotoxicitydieneexperienceimprovedmemberneoplastic cellnovelnovel therapeuticsoperationoutcome forecastoxidationscaffoldskillsstereochemistry
中文摘要
项目总结
癌症是美国第二大死亡原因,而且已经成为一种严重的
给社会带来经济负担。在最成功的治疗中,天然产品受到启发
紫杉醇、长春瑞滨和埃布林等化疗药物显著延长了人肺癌的寿命。
数百万癌症患者。据报道,超过75%的新化学实体
在1940年至2010年期间作为抗癌剂提交给食品和药物管理局
天然的产品来源。我们建议开发一种新的氧化脱芳构化方法来获得
生物活性天然产物的核心结构及其在全合成中的应用
瑞香素A的合成,一种对小鼠淋巴瘤细胞有显著细胞毒性的生物碱。
因为一些亚型的淋巴瘤不会形成实体瘤,他们的治疗通常包括
高强度的放射治疗和化疗。改善低耐受性患者的预后
对于目前的大剂量化疗方案,迫切需要新的疗效更好的治疗药物。vt.给出
瑞香生物碱的细胞毒性研究对瑞香素A的生物学研究具有重要意义
并探索其成为治疗剂的潜力。
我们的初步数据表明,对映体选择性的Michael加成/氧化脱芳构化
可以通过一锅操作实现级联,并以极佳的性能获得所需的产品
立体选择性和产率,突出了我们的合成策略的显著效率
这些天然产品。当对位取代苯酚进行脱芳构化时,
三尖杉酯类化合物的结构可方便地制备。当邻位取代苯酚
在脱芳构化过程中被截留,螺环中间体可以作为二烯在脱芳构化过程中使用
随后进行[4+2]环加成反应,得到瑞香素A型生物碱骨架。在建议的
研究我们将1)确定合适的单电子转移试剂和碱,以使
均相条件下敏感底物的脱芳构化;2)研究区域选择性
不对称取代芳烃;3)考察螺二烯在
4)阐明了控制手性的立体化学决定因素。
5)将新方法学应用于瑞香素A及其衍生物的合成。
与药物相关的类似物。
英文摘要
PROJECT SUMMARY
Cancer is the second leading cause of deaths in the United States and it has become a serious
economic burden to society. Among the most successful treatments, natural product inspired
chemotherapies such as Paclitaxel, Navelbine and Eribulin have significantly extended the life span of
millions of cancer patients. It has been reported that more than 75% of the new chemical entities
submitted to the Food and Drug Administration as anticancer agents between 1940 and 2010 have
natural product origins. We propose to develop a novel oxidative dearomatization methodology to access
the core structures of biologically active natural products and investigate its application to the total
synthesis of daphmanidin A, an alkaloid showing significant cytotoxicity against murine lymphoma cells.
Because some subtypes of lymphoma do not form solid tumors, their treatments commonly involve
intense radiotherapy and chemotherapy. To improve the prognosis of patients who show low tolerance
to current high dose regimens, new therapeutic agents with better efficacy are urgently needed. Given
the cytotoxicity profiles of Daphniphyllum alkaloids, it is important to study the biology of daphmanidin A
and explore its potential to become a therapeutic agent.
Our preliminary data have shown that an enantioselective Michael addition / oxidative dearomatization
cascade can be achieved by a one-pot operation, and the desired products are obtained with excellent
stereoselectivity and yields, highlighting the remarkable efficiency of our strategy for the synthesis of
these natural products. When para substituted phenols are subjected to the dearomatization, the core
structures of Cephalotaxus norditerpenes are conveniently produced. When ortho substituted phenols
are intercepted during the dearomatization, the spiro intermediates can serve as dienes in the
subsequent [4+2] cycloaddition, resulting in the daphmanidin A type alkaloid skeletons. In the proposed
research we will 1) identify the suitable single electron transfer reagent and base to enable the
dearomatization for sensitive substrates under homogenous conditions; 2) study the regioselectivity for
asymmetrically substituted aromatics; 3) examine the conditions to intercept spiro diene in the
dearomatization; 4) elucidate the stereochemistry determining elements that control the chirality of the
quaternary carbon center, and 5) apply the novel methodology to the synthesis of daphmanidin A and its
pharmaceutically relevant analogues.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MOLECULAR MECHANISM OF HISTONE ACETYLATION
-
批准号:8363357
-
项目类别:
-
资助金额:$0.78万
-
财政年份:2011
-
负责人:Yu Yuan
-
依托单位:
MOLECULAR MECHANISM OF HISTONE ACETYLATION
-
批准号:8170603
-
项目类别:
-
资助金额:$1.39万
-
财政年份:2010
-
负责人:Yu Yuan
-
依托单位:
MOLECULAR MECHANISM OF HISTONE ACETYLATION
-
批准号:7957289
-
项目类别:
-
资助金额:$2.01万
-
财政年份:2009
-
负责人:Yu Yuan
-
依托单位:
PROTEIN/SIRNA COMPLEX
-
批准号:7957248
-
项目类别:
-
资助金额:$2.32万
-
财政年份:2009
-
负责人:Yu Yuan
-
依托单位:
国内基金
海外基金
Iboga alkaloids骨架导向的不对称串联反应构建吖庚环并[4,5-b]吲哚及其在全合成中的应用
-
批准号:21801032
-
项目类别:青年科学基金项目
-
资助金额:26.0万元
-
批准年份:2018
-
负责人:陈惠渝
-
依托单位: